AI-powered technology for early rheumatic detection utilize advanced algorithms and machine learning models to identify potential signs of rheumatic diseases, leading to prompt intervention and improved patient outcomes.
Medirion has been selected as part of Batch #8 of HIGH-TECH.NRW, joining a cohort of outstanding startups for twelve weeks of intensive innovation and growth.
Link
Join our team
We are building all our prototypes and
code all our software inhouse to test and
validate as fast as possible.
With the right team and the possible applications, we are going to push the boundaries of early diagnostics.